210 related articles for article (PubMed ID: 35887382)
1. Integrated DNA Copy Number and Expression Profiling Identifies IGF1R as a Prognostic Biomarker in Pediatric Osteosarcoma.
Taylor AM; Sun JM; Yu A; Voicu H; Shen J; Barkauskas DA; Triche TJ; Gastier-Foster JM; Man TK; Lau CC
Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35887382
[TBL] [Abstract][Full Text] [Related]
2. Whole exome sequencing of a single osteosarcoma case--integrative analysis with whole transcriptome RNA-seq data.
Reimann E; Kõks S; Ho XD; Maasalu K; Märtson A
Hum Genomics; 2014 Dec; 8(1):20. PubMed ID: 25496518
[TBL] [Abstract][Full Text] [Related]
3. Transcriptional Profiling Identifies the Signaling Axes of IGF and Transforming Growth Factor-b as Involved in the Pathogenesis of Osteosarcoma.
Yang R; Piperdi S; Zhang Y; Zhu Z; Neophytou N; Hoang BH; Mason G; Geller D; Dorfman H; Meyers PA; Healey JH; Phinney DG; Gorlick R
Clin Orthop Relat Res; 2016 Jan; 474(1):178-89. PubMed ID: 26463566
[TBL] [Abstract][Full Text] [Related]
4. Correlation of IGF1R expression with ABCG2 and CD44 expressions in human osteosarcoma.
Kim CK; Oh S; Kim SJ; Leem SH; Heo J; Chung SH
Genes Genomics; 2018 Apr; 40(4):381-388. PubMed ID: 29892839
[TBL] [Abstract][Full Text] [Related]
5. LncRNA SOX2-OT is a novel prognostic biomarker for osteosarcoma patients and regulates osteosarcoma cells proliferation and motility through modulating SOX2.
Wang Z; Tan M; Chen G; Li Z; Lu X
IUBMB Life; 2017 Nov; 69(11):867-876. PubMed ID: 28960757
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of G Protein-Coupled Receptor Kinase 2 Promotes Unbiased Downregulation of IGF1 Receptor and Restrains Malignant Cell Growth.
Crudden C; Shibano T; Song D; Dragomir MP; Cismas S; Serly J; Nedelcu D; Fuentes-Mattei E; Tica A; Calin GA; Girnita A; Girnita L
Cancer Res; 2021 Jan; 81(2):501-514. PubMed ID: 33158816
[TBL] [Abstract][Full Text] [Related]
7. Increased expression of insulin-like growth factor-1 receptor is correlated with worse survival in canine appendicular osteosarcoma.
Maniscalco L; Iussich S; Morello E; Martano M; Gattino F; Miretti S; Biolatti B; Accornero P; Martignani E; Sánchez-Céspedes R; Buracco P; De Maria R
Vet J; 2015 Aug; 205(2):272-80. PubMed ID: 25257352
[TBL] [Abstract][Full Text] [Related]
8. Copy number gains in EGFR and copy number losses in PTEN are common events in osteosarcoma tumors.
Freeman SS; Allen SW; Ganti R; Wu J; Ma J; Su X; Neale G; Dome JS; Daw NC; Khoury JD
Cancer; 2008 Sep; 113(6):1453-61. PubMed ID: 18704985
[TBL] [Abstract][Full Text] [Related]
9. MiR-384 Inhibits Malignant Biological Behavior Such as Proliferation and Invasion of Osteosarcoma by Regulating IGFBP3.
Tan Y; Chen L; Li S; Hao H; Zhang D
Technol Cancer Res Treat; 2020; 19():1533033820909125. PubMed ID: 32129151
[TBL] [Abstract][Full Text] [Related]
10. The genetic basis for inactivation of Wnt pathway in human osteosarcoma.
Du X; Yang J; Yang D; Tian W; Zhu Z
BMC Cancer; 2014 Jun; 14():450. PubMed ID: 24942472
[TBL] [Abstract][Full Text] [Related]
11. IR/IGF1R signaling as potential target for treatment of high-grade osteosarcoma.
Kuijjer ML; Peterse EF; van den Akker BE; Briaire-de Bruijn IH; Serra M; Meza-Zepeda LA; Myklebost O; Hassan AB; Hogendoorn PC; Cleton-Jansen AM
BMC Cancer; 2013 May; 13():245. PubMed ID: 23688189
[TBL] [Abstract][Full Text] [Related]
12. Insulin-Like Growth Factor and SLC12A7 Dysregulation: A Novel Signaling Hallmark of Non-Functional Adrenocortical Carcinoma.
Brown TC; Nicolson NG; Stenman A; Juhlin CC; Gibson CE; Callender GG; Korah R; Carling T
J Am Coll Surg; 2019 Sep; 229(3):305-315. PubMed ID: 31034883
[TBL] [Abstract][Full Text] [Related]
13. Overactivation of the IGF signalling pathway in osteosarcoma: a potential therapeutic target?
Ameline B; Kovac M; Nathrath M; Barenboim M; Witt O; Krieg AH; Baumhoer D
J Pathol Clin Res; 2021 Mar; 7(2):165-172. PubMed ID: 33295144
[TBL] [Abstract][Full Text] [Related]
14. Insulin-like growth factor 1 receptor and response to anti-IGF1R antibody therapy in osteosarcoma.
Cao Y; Roth M; Piperdi S; Montoya K; Sowers R; Rao P; Geller D; Houghton P; Kolb EA; Gill J; Gorlick R
PLoS One; 2014; 9(8):e106249. PubMed ID: 25170759
[TBL] [Abstract][Full Text] [Related]
15. Increased expression of insulin-like growth factor-1 receptor is correlated with tumor metastasis and prognosis in patients with osteosarcoma.
Wang YH; Han XD; Qiu Y; Xiong J; Yu Y; Wang B; Zhu ZZ; Qian BP; Chen YX; Wang SF; Shi HF; Sun X
J Surg Oncol; 2012 Mar; 105(3):235-43. PubMed ID: 21866554
[TBL] [Abstract][Full Text] [Related]
16. microRNA-194 suppresses osteosarcoma cell proliferation and metastasis in vitro and in vivo by targeting CDH2 and IGF1R.
Han K; Zhao T; Chen X; Bian N; Yang T; Ma Q; Cai C; Fan Q; Zhou Y; Ma B
Int J Oncol; 2014 Oct; 45(4):1437-49. PubMed ID: 25096247
[TBL] [Abstract][Full Text] [Related]
17. Heterozygous retinoblastoma gene mutation compromises in vitro osteogenesis of adipose mesenchymal stem cells - a temporal gene expression study.
Vincent A; Natarajan V; Khetan V; Krishnakumar S; Parameswaran S
Exp Cell Res; 2020 Nov; 396(1):112263. PubMed ID: 32890459
[TBL] [Abstract][Full Text] [Related]
18. Integrative analysis reveals relationships of genetic and epigenetic alterations in osteosarcoma.
Kresse SH; Rydbeck H; Skårn M; Namløs HM; Barragan-Polania AH; Cleton-Jansen AM; Serra M; Liestøl K; Hogendoorn PC; Hovig E; Myklebost O; Meza-Zepeda LA
PLoS One; 2012; 7(11):e48262. PubMed ID: 23144859
[TBL] [Abstract][Full Text] [Related]
19. Downregulation of lncRNA SNHG12 reversed IGF1R-induced osteosarcoma metastasis and proliferation by targeting miR-195-5p.
Xu N; Xu J; Zuo Z; Liu Y; Yan F; Han C
Gene; 2020 Feb; 726():144145. PubMed ID: 31743769
[TBL] [Abstract][Full Text] [Related]
20. Integrative genomic analysis of matched primary and metastatic pediatric osteosarcoma.
Negri GL; Grande BM; Delaidelli A; El-Naggar A; Cochrane D; Lau CC; Triche TJ; Moore RA; Jones SJ; Montpetit A; Marra MA; Malkin D; Morin RD; Sorensen PH
J Pathol; 2019 Nov; 249(3):319-331. PubMed ID: 31236944
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]